LEXINGTON, Mass., May 14, 2012 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced its support of the first global hereditary angioedema (HAE) awareness day, being held on May 16th, with a new Facebook page "Shire Supports HAE Awareness Day." Developed to help raise awareness of HAE, for every person who likes the Facebook page by May 16th, Shire will donate $1 to the U.S. Hereditary Angioedema Association (HAEA) up to $7,500. Visitors can learn more about HAE or share comments by clicking on the page's "Join the Discussion!" tab where new facts about this rare condition are posted each day.
"Shire is dedicated to enabling people with life-altering conditions like HAE to lead better lives. This means not only providing much needed treatments for rare diseases, but also supporting awareness and education initiatives like HAE Awareness Day," said Hugh Cole, Global HAE Franchise Lead, Shire HGT. "I want to thank the 1,600 people who have already liked our Facebook page, and I encourage more people to visit the site and join in our effort. Liking the page is a fast and effective way to lend your support to HAE Awareness Day and the U.S. HAEA."
HAE Awareness Day was initiated by the HAEi, the International Patient Organization for C1 Inhibitor Deficiency, along with support from its National Member Organizations including the U.S. HAEA. It is a global initiative to raise awareness of HAE among the general public and medical community with the aim of providing patients with better care, earlier and more accurate diagnosis.
"This first annual global HAE awareness day will put a spotlight on HAE's impact on patients and their families," said Janet Long, Executive Vice President of the U.S. HAEA. "There remains a pressing need to broaden awareness of HAE so that people who suffer from recurring bou
|SOURCE Shire plc|
Copyright©2010 PR Newswire.
All rights reserved